Oligomerization of a Glucagon-like Peptide 1 Analog: Bridging Experiment and Simulations

Biophysical Journal

Volumn 109, Issue 6, 2015, Pages 1202-1213

  Frederiksen, Tine M ^a   Sønderby, Pernille ^a   Ryberg, Line A ^a   Harris, Pernille ^a   Bukrinski, Jens T ^b   Scharff Poulsen, Anne M ^b   Elf Lind, Maria N ^a   Peters, Günther H ^a  

^a TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^b NOVOZYMES A S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

LIRAGLUTIDE; SOLVENT; WATER;

AMINO ACID SEQUENCE; CHEMICAL PHENOMENA; CHEMISTRY; METABOLISM; MOLECULAR DYNAMICS; PROTEIN MULTIMERIZATION; SMALL ANGLE SCATTERING; X RAY DIFFRACTION;

AMINO ACID SEQUENCE; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; LIRAGLUTIDE; MOLECULAR DYNAMICS SIMULATION; PROTEIN MULTIMERIZATION; SCATTERING, SMALL ANGLE; SOLVENTS; WATER; X-RAY DIFFRACTION;

EID: 84941805635     PISSN: 00063495     EISSN: 15420086     Source Type: Journal    
DOI: 10.1016/j.bpj.2015.07.051     Document Type: Article

References (50)

1. A.A. Kaspar, and J.M. Reichert Future directions for peptide therapeutics development Drug Discov. Today 18 2013 807 817
2. Y. Li, and M. Shao M. Gong Self-assembling peptides improve the stability of glucagon-like peptide-1 by forming a stable and sustained complex Mol. Pharm. 10 2013 3356 3365
3. X. Chang, and D. Keller J.J. Led NMR studies of the aggregation of glucagon-like peptide-1: formation of a symmetric helical dimer FEBS Lett. 515 2002 165 170
4. F.S. Willard, and K.W. Sloop Physiology and emerging biochemistry of the glucagon-like peptide-1 receptor Exp. Diabetes Res. 2012 2012 470851
5. M.A. Nauck Liraglutide, a once-daily human GLP-1 analogue Br. J. Diabetes Vasc. Dis. 8 2008 S26 S33
6. H.-J. Jang, and Z. Kokrashvili J.M. Egan Gut-expressed gustducin and taste receptors regulate secretion of glucagon-like peptide-1 Proc. Natl. Acad. Sci. USA 104 2007 15069 15074
7. S. Moran-Ramos, A.R. Tovar, and N. Torres Diet, friend or foe of enteroendocrine cells: how it interacts with enteroendocrine cells Adv. Nutr. Int. Rev. J. 3 2012 8 20
8. K. Sakurai, and E.Y. Lee T. Miki Glucagon-like peptide-1 secretion by direct stimulation of L cells with luminal sugar vs non-nutritive sweetener J. Diabetes Investig. 3 2012 156 163
9. M.E. Doyle, and J.M. Egan Mechanisms of action of glucagon-like peptide 1 in the pancreas Pharmacol. Ther. 113 2007 546 593
10. S. Madsbad The role of glucagon-like peptide-1 impairment in obesity and potential therapeutic implications Diabetes Obes. Metab. 16 2014 9 21
11. S. Briyal, S. Shah, and A. Gulati Neuroprotective and anti-apoptotic effects of liraglutide in the rat brain following focal cerebral ischemia Neuroscience 281C 2014 269 281
12. K. Talbot, and H.Y. Wang The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer's disease Alzheimers Dement. 10 Suppl 1 2014 S12 S25
13. K. Velmurugan, and R. Bouchard S. Pugazhenthi Neuroprotective actions of glucagon-like peptide-1 in differentiated human neuroprogenitor cells J. Neurochem. 123 2012 919 931
14. L. Zhao, and J. Xu Y. Fang Protective effect of rhGLP-1 (7-36) on brain ischemia/reperfusion damage in diabetic rats Brain Res. 1602 2015 153 159
15. P.L. McClean, and C. Hölscher Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease Neuropharmacology 76 Pt A 2014 57 67
16. C.F. Deacon Therapeutic strategies based on glucagon-like peptide 1 Diabetes 53 2004 2181 2189
17. H.M. Tasyurek, and H.A. Altunbas S. Sanlioglu Incretins: their physiology and application in the treatment of diabetes mellitus Diabetes Metab. Res. Rev. 30 2014 354 371
18. D.J. Drucker, and M.A. Nauck The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes Lancet 368 2006 1696 1705
19. C. Orskov, A. Wettergren, and J.J. Holst Biological effects and metabolic rates of glucagonlike peptide-1 7-36 amide and glucagonlike peptide-1 7-37 in healthy subjects are indistinguishable Diabetes 42 1993 658 661
20. A. Lund, F.K. Knop, and T. Vilsbøll Glucagon-like peptide-1 receptor agonists for the treatment of type 2 diabetes: differences and similarities Eur. J. Intern. Med. 25 2014 407 414
21. B. Gallwitz, and T. Ropeter W.E. Schmidt GLP-1-analogues resistant to degradation by dipeptidyl-peptidase IV in vitro Regul. Pept. 86 2000 103 111
22. B. Ahrén GLP-1 for type 2 diabetes Exp. Cell Res. 317 2011 1239 1245
23. E.E. Ladenheim Liraglutide and obesity: a review of the data so far Drug Des. Devel. Ther. 9 2015 1867 1875
24. F. Bemporad, and F. Chiti Protein misfolded oligomers: experimental approaches, mechanism of formation, and structure-toxicity relationships Chem. Biol. 19 2012 315 327
25. D. Russell-Jones Molecular, pharmacological and clinical aspects of liraglutide, a once-daily human GLP-1 analogue Mol. Cell. Endocrinol. 297 2009 137 140
26. L.B. Knudsen, and P.F. Nielsen H. Agersø Potent derivatives of glucagon-like peptide-1 with pharmacokinetic properties suitable for once daily administration J. Med. Chem. 43 2000 1664 1669
27. K. Pabreja, and M.A. Mohd S.G.B. Furness Molecular mechanisms underlying physiological and receptor pleiotropic effects mediated by GLP-1R activation Br. J. Pharmacol. 171 2014 1114 1128
28. D.B. Steensgaard, and J.K. Thomsen L.B. Knudsen The molecular basis for the delayed absorption of the once-daily Human GLP-1 analogue, liraglutide Diabetes 57 Suppl 1 2008 A164
29. Y. Wang, and A. Lomakin G.B. Benedek Transformation of oligomers of lipidated peptide induced by change in pH Mol. Pharm. 12 2015 411 419
30. S. Trier, and L. Linderoth U.L. Rahbek Acylation of Glucagon-like peptide-2: interaction with lipid membranes and in vitro intestinal permeability PLoS One 9 2014 e109939
31. X. Chang, and D. Keller J.J. Led Structure and folding of glucagon-like peptide-1-(7-36)-amide in aqueous trifluoroethanol studied by NMR spectroscopy Magn. Reson. Chem. 39 2001 477 483
32. RxList, The Internet Drug Index. 2015. Victoza. http://www.rxlist.com/victoza-drug.htm. Accessed July 5, 2015.
33. E. Gasteiger, and C. Hoogland A. Bairoch Protein identification and analysis tools in the ExPASy server The Proteomics Protocols Handbook 2005 Humana Press New York 571 607
34. E. Gasteiger, and A. Gattiker A. Bairoch ExPASy: the proteomics server for in-depth protein knowledge and analysis Nucleic Acids Res. 31 2003 3784 3788
35. A. Labrador, and Y. Cerenius T. Plivelic The yellow mini-hutch for SAXS experiments at MAX IV Laboratory J. Phys. Conf. Ser. 425 2013 72019
36. P.V. Konarev, and V.V. Volkov D.I. Svergun PRIMUS: a Windows PC-based system for small-angle scattering data analysis J. Appl. Cryst. 36 2003 1277 1282
37. M.V. Petoukhov, and D. Franke D.I. Svergun New developments in the ATSAS program package for small-angle scattering data analysis J. Appl. Cryst. 45 2012 342 350
38. A.V. Semenyuk, and D.I. Svergun GNOM. A program package for small-angle scattering data processing J. Appl. Cryst. 24 1991 537 540
39. F.C. Bernstein, and T.F. Koetzle M. Tasumi The Protein Data Bank. A computer-based archival file for macromolecular structures Eur. J. Biochem. 80 1977 319 324
40. Grubmüller, H., and V. Groll. 2015. SOLVATE. Biophysical Chemistry Department, Max Planck Institute of Biophysics, Frankfurt, Germany. http://www.mpibpc.mpg.de/grubmueller/solvate. Accessed February 28, 2015.
41. W.L. Jorgensen, and J. Chandrasekhar M.L. Klein Comparison of simple potential functions for simulating liquid water J. Chem. Phys. 79 1983 926
42. M.T. Nelson, and W. Humphrey K. Schulten NAMD: a parallel, object-oriented molecular dynamics program Int. J. High Perform. Comput. Appl. 10 1996 251 268
43. A.D. MacKerell, and D. Bashford M. Karplus All-atom empirical potential for molecular modeling and dynamics studies of proteins J. Phys. Chem. B 102 1998 3586 3616
44. J.J. Madsen, and L. Linderoth G.H. Peters Secretory phospholipase A2 activity toward diverse substrates J. Phys. Chem. B 115 2011 6853 6861
45. W. Humphrey, A. Dalke, and K. Schulten VMD: visual molecular dynamics J. Mol. Graph. 14 1996 33 38 27-28
46. D. Svergun, C. Barberato, and M.H. Koch CRYSOL - a program to evaluate x-ray solution scattering of biological macromolecules from atomic coordinates J. Appl. Cryst. 28 1995 768 773
47. E. Mylonas, and D.I. Svergun Accuracy of molecular mass determination of proteins in solution by small-angle x-ray scattering J. Appl. Cryst. 40 2007 s245 s249
48. T. Darden, D. York, and L. Pedersen Particle mesh Ewald: an N log(N) method for Ewald sums in large systems J. Chem. Phys. 98 1993 10089 10092
49. U. Essmann, and L. Perera L.G. Pedersen A smooth particle mesh Ewald method J. Chem. Phys. 103 1995 8577 8593
50. S.E. Feller, and Y. Zhang B.R. Brooks Constant-pressure molecular-dynamics simulation - the Langevin piston method J. Chem. Phys. 103 1995 4613 4621